Subscribe to Specialty Providers

Specialty Providers

KCI sells to 3M


SAN ANTONIO and NEW YORK – A consortium of funds led by Apax Partners has entered into a definitive agreement to sell Acelity and its KCI subsidiaries worldwide to 3M for about $6.725 billion.

Q&A: Option Care's John Rademacher


When the ink dries on the planned merger of two of the country’s leading home infusion services providers, it will form an organization that is deeply committed to patient care, says John Rademacher, CEO of the combined company of Option Care and BioScri

O&P stakeholders take next steps to preserve access


WASHINGTON – O&P stakeholders plan to use a recent massive fraud takedown involving medically unnecessary knee and back braces to advance upcoming legislation.

New PHS CEO, inspired by patients, seeks innovation


ROSEVILLE, Minn. – New CEO Cameo Zehnder has built an entire career at Pediatric Home Service, an independent pediatric homecare company based here.

Arriva execs settle allegations


NASHVILLE, Tenn. – Two former Arriva Medical executives have settled allegations they violated the False Claims Act by agreeing to pay $500,000 each.

Vent providers fear worst

‘We’re really just being asked to cut our rate and offer no other support’

YARMOUTH, Maine – The lack of clear guidance for non-invasive ventilators could make it difficult to calculate bids for the product and could, ultimately, compromise patient care, say providers.

Mystery surrounds nat’l mail-order program for diabetes testing supplies


WASHINGTON – With the national mail-order program for diabetes testing supplies on hold indefinitely, it’s anybody’s guess what will happen next.

AOPA criticizes ‘unscrupulous’ providers


ALEXANDRIA, Va. – The American Orthotic & Prosthetic Association is “strongly opposed” to lead-generation marketing for orthoses, a business practice that it says is responsible for an increase in fraud and abuse, the association said in a statement today.

OIG: Three strips dominate market


WASHINGTON – The top three types of diabetes test strips accounted for just over half of the non-mail order market, and the top 10 types accounted for approximately 93% of the market, according to a new report from the Office of Inspector General.